Juan C Osorio MD
@juanosoriomd
Followers
1K
Following
5K
Media
65
Statuses
839
Medical Oncologist & Physician Scientist @MSKCancerCenter @RockefellerUniv / GMO, Cancer immunology / alum: @MSKCancerCenter @WeillCornell, @MedicinaUNAL šØš“
Manhattan, NY
Joined March 2017
Please join us, exciting work discussions myeloid targets for cancer immunotherapy! .#JACI.
Anti-CD47/CD40 antibodies are emerging as new IO treatment options! Explore recent updates on these antibodies with an expert presentation from a former SITC abstract presenter @juanosoriomd at the 29th JACI Annual Meeting July 24-26 in Japan or virtual:
1
1
18
RT @sitcancer: Anti-CD47/CD40 antibodies are emerging as new IO treatment options! Explore recent updates on these antibodies with an experā¦.
0
1
0
RT @bbmdmsk: Cutting edge research by the Glickman lab. Intersecting areas of infectious disease and oncology leading to a better understanā¦.
0
9
0
RT @BraunMDPhD: We are looking for an associate research scientist and lab manager for our translational cancer immunology lab at Yale. Pā¦.
jobrxiv.org
Post a job in 3min, or find thousands of job offers like this one at jobRxiv!
0
30
0
Join us at #CICON25, September 10-12 in Utrecht. This is an exciting venue to explore how novel insights in immuno-oncology can translate into life-changing outcomes! Review the program, submit an abstract and register today:
0
1
3
RT @PatelOncology: Great @AACR clinical trial plenary on Biologics and T cell Engagers chaired by @wolchokj #crystalmackall with outstandinā¦.
0
8
0
Great discussion today at #AACR25 on myeloid targeting therapies and induction of immune-privilege sites within the TME through biologics. Thank you to @wolchokj and Crystal Mackall for moderating the session, and @SGoswamiMDPhD for the amazing discussion on this topic.
3
5
24
RT @christine_lovly: @juanosoriomd presents his beautiful translational work on CD40 agonist 2141-V11. #TLS formation implicated response iā¦.
0
4
0
Interested in assessing antibody-dependent cellular phagocytosis by primary macrophages? Here is a practical and optimized protocol developed by dedicated and talented members of the lab, enjoy!
0
0
5
Interested in myeloid cell anti-tumor immunity? Iāll be presenting at @theNCI Rising Scholars Seminar Series on 17 Apr our work on Fc-optimized CD40 Agonistic Antibody and TLS formation and induction of Systemic Antitumor Immunity
cassyni.com
CD40 agonistic antibodies are an attractive strategy to activate antigen-presenting cells (APC) and initiate antitumor immune responses. ...
2
7
24
So important to spread all the effort that goes through NIH grant submissions, and the ramifications of holding these efforts at so many levels.
I need people to understand how difficult it is to get an NIH grant. You spend months writing a proposal, following strict guidelines that include a detailed multiyear budget, bios of everyone on your team, plans for participant safety & ethical conduct. Then you send it off -1/n.
0
0
5
RT @csgarrix: I am pleased to announce our latest review article published in @trendscancer ! In this review, we summarize recent advancesā¦.
0
4
0
RT @ImmunityCP: Online now: Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to termā¦.
cell.com
The balance of TĀ cells in a progenitor-exhausted state and those in a terminally exhausted state is a critical determinant of anti-tumor responses. Waibl Polania, Hoyt-Miggelbrink, etĀ al. identify...
0
61
0
RT @VJOncology: š„@juanosoriomd of @MSKCancerCenter discusses a Phase I study on 2141-V11, an anti-CD40 antibody designed to enhance FcĪ³RIIBā¦.
vjoncology.com
Juan Osorio, MD, Memorial Sloan Kettering Cancer Center, The Rockefeller University, New York, NY, introduces an in-human Phase I study (NCT04059588), which explored the efficacy and safety of...
0
1
0
Thrilled to present updates on our work in this session with amazing and inspiring leaders in the field. Please join us this Thursday!
Looking forward to moderating this @sitcancer Deep Dive into Co-stim along w @merghout featuring 3 tremendous talks from rising stars in the field covering novel strategies, ICI combos & CART @hamieh @juanosoriomd & @RZappasodi. Plz register & join us!.
0
3
21
Hope to see the science/MedOnc community at š āļø š¦ same handle! See you there!
0
0
16
Heading to @sitcancer conference #SITC24. Thrilled to present work on our Fc-engineered anti-CD40 antibody and induction of tertiary lymphoid structures and systemic immunity in patients with metastatic cancer. Tomorrow at 12:30. See you there!
0
1
12